Let’s Meet the Virologists

LMtV Episode 21: Harnessing viruses to target cancer

We talk with Dr. Sharmila Nair, a staff scientist, about her work investigating how Zika virus might be used to target a fatal human cancer, Glioblastoma multiforme.

LMtV Episode 20: Searching for new therapeutics and addressing vaccine hesitancy to combat COVID-19

We talk with Dr. Tristan Jordan, a postdoctoral scholar, about his work using a CRISPR screen and proteomics of the viral replication complex to identity potential drug targets for SARS-CoV-2.

LMtV Episode 19: warp speed - light at the end of the tunnel!

We talk with Dr. Rachel Presti, an associate professor, about her work with clinical trials to examine how well different drugs, therapies, and vaccines work to prevent and treat COVID-19.

LMtV Episode 18: hang in there - the end is in sight!

We talk with Dr. Brett Case, a postdoctoral researcher, about his work identifying and characterizing numerous monoclonal antibodies against SARS-CoV-2.

LMtV Episode 17: the interplay between viruses and the immune response

We talk with Dr. Sigrid Gouma, a postdoctoral researcher, who has been examining antibody responses during SARS-CoV-2 infection to determine the impact of COVID-19 on specific populations such as pregnant women and to prevent transmission from those with asymptomatic infection.

LMtV Episode 16: a balancing act

We talk with Dr. Ben Israelow, an infectious diseases fellow, about his work using small animal models and human patient samples to determine why some patients recover from COVID-19 while others do not.

LMtV Episode 15: harnessing the immune response to develop therapies

We talk with Dr. Laura VanBlargen, a staff scientist, about her work to develop and characterize new monoclonal antibody-based therapies for SARS-CoV-2.

LMtV Episode 14: from bench to bedside

We talk with Dr. David Martinez, a postdoctoral researcher, about his work evaluating therapies and vaccines against SARS-CoV-2.